Amani Therapeutics

Amani Therapeutics was founded in 2025, is headquartered in New York, United States, lists 11–50 employees, and has $25.0M in recorded funding across 1 round.

Headquarters
New York
Employees
11–50
Founded
2025
Business Model
B2B2C
Total Funding
$25.0M
Last Round
$25.0M Series AMar 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

Amani Therapeutics is a New York-based biopharmaceutical company developing safer, more effective treatments for serious psychiatric illness. Its lead program, AM-01, is a fixed-dose combination of clozapine and a Phase 3-ready novel chemical entity in-licensed from AstraZeneca, designed to deliver clozapine's unmatched efficacy for treatment-resistant schizophrenia while addressing its most significant safety liability, severe neutropenia, and reducing the burdensome blood-monitoring requirements that limit its use today.

Summary

Amani Therapeutics is a Biotech company based in New York, United States, founded in 2025. It lists 11–50 employees. It has raised $25.0M in total across 1 round, most recently a $25.0M Series A round in Mar 2026. Investors include RTW Investments.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AMar 2026
$25.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Amani Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/amani-therapeutics"><img src="https://indexed.vc/api/badge/company/amani-therapeutics" alt="Amani Therapeutics on Indexed.vc" width="260" height="76" /></a>